
The preoperative condition of the ocular surface affects outcomes after implantation of IOLs in patients undergoing cataract surgery.

The preoperative condition of the ocular surface affects outcomes after implantation of IOLs in patients undergoing cataract surgery.

Topcon Medical Laser Systems Inc. has launched a system upgrade for its family of lasers offering scanning technology and tissue-sparing sub-threshold treatment options.

Results of a prospective, randomized pilot study suggest that a topical nonsteroidal anti-inflammatory drug, bromfenac 0.09%, may be a useful addition to an anti-vascular endothelial growth factor agent, intravitreal ranibizumab, in patients being treated for exudative age-related macular degeneration.

The UV + riboflavin crosslinking procedure triggers the development of mild stromal haze in rabbit corneas, but it is not because of myofibroblast generation,a s it is for late haze after PRK.

Microincisional vitrectomy surgery using 23- and 25+-gauge instrumentation enhances the surgical management of complex macular pathologies.

A number of procedures are available to address presbyopia, each with its advantages and disadvantages.

Careful investigation using a systematic approach to troubleshoot patients dissatisfied after multifocal IOL implantation usually can identify an underlying cause that can be effectively managed with conservative intervention and avoidance of further intraocular surgery.

Julia A. Haller, MD, details the complex medical case of a blind African teeneager recently freed from slavery in the Sudan.

A triple-function 23-gauge laser endoscope is available for video, imaging, and laser during an array of retinal procedures.

A new aspheric treatment for presbyopia, P-curve, considers both the total Q value and the corneal asphericity among other parameters to induce the negative spherical aberration that is lost with aging.

Results of a prospective, double-masked, randomized study indicate that combination treatment with the dexamethasone implant 0.7 mg and laser photocoagulation is very well tolerated in patients with DDME and provides better functional and anatomic outcomes than laser treatment alone.

An ultra-small cataract incision size might not be optimal to maintain wound integrity.

A newly developed proprietary injector system allows implantation of the investigational fluid-filled accommodating IOL through a small incision.

The mature, brunescent nucleus is a challenge for all phaco surgeons.

Patients with severe or progressive zonulopathy are at risk for late postoperative subluxation or dislocation of a capsular tension ring-IOL-capsular bag complex, which occurred about 6 years after implantation.

Results from 2 years of follow-up in a study of presbyopia correction with femtosecond laser intrastromal correction show continued safety, refractive stability, and maintenance of improvements in near visual acuity.

The Hippocratic Oath is a connection to ancient times and a call for humans to exhibit honorable behavior.

Diplopia is an unexpected and unwelcome complication that can occur, albeit rarely, after refractive surgery.

Based on the fact that extraordinary customer service can be a game changer to help position your practice for success in this unstable economy, this article builds from last month's piece on customer service.

Sun glare is a year-round problem, not just a summertime occurrence.

Dispensing high-end eyeglass frames is not as difficult as it may seem.

An ophthalmic surgical simulator improved residents' operating room performance during phacoemulsification and improved patient outcomes.

With the Office of Inspector General's heightened awareness of coding and documentation errors, physicians should be aware of some specific areas to check and double-check in their daily routine of documentation.

As results from the FDA IDE clinical trial are awaited, analyses of data from patients receiving earlier versions of an investigational presbyopia-correcting intracorneal inlay show that its efficacy for improving near vision remains stable for at least 3 years.

The future of glaucoma medical therapy is contingent upon the correlation of ocular surface disease and glaucoma.